These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9600795)

  • 1. Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.
    Herrala J; Puolijoki H; Liippo K; Raitio M; Impivaara O; Tala E; Nieminen MM
    Bone; 1998 May; 22(5):577-82. PubMed ID: 9600795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study.
    Matsumoto H; Ishihara K; Hasegawa T; Umeda B; Niimi A; Hino M
    Chest; 2001 Nov; 120(5):1468-73. PubMed ID: 11713121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention with clodronate of osteoporosis secondary to inhaled corticosteroid treatment in patients with chronic asthmatic bronchitis.
    Muratore M; Santacesaria G; Quarta E; Calcagnile F; Cosentino L; Muratore L
    Int J Clin Pharmacol Res; 2000; 20(3-4):61-4. PubMed ID: 11314239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
    Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
    Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
    Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer.
    Rizzoli R; Forni M; Schaad MA; Slosman DO; Sappino AP; Garcia J; Bonjour JP
    Bone; 1996 Jun; 18(6):531-7. PubMed ID: 8805993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.
    Luengo M; del Río L; Pons F; Picado C
    Eur Respir J; 1997 Sep; 10(9):2110-3. PubMed ID: 9311512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular clodronate in nonresponders to oral alendronate therapy for osteoporosis.
    del Puente A; Scognamiglio A; Itto E; Ferrara G; Oriente P
    J Rheumatol; 2000 Aug; 27(8):1980-3. PubMed ID: 10955341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
    Gnudi S; Lisi L; Fini M; Malavolta N
    Int J Tissue React; 2001; 23(1):33-7. PubMed ID: 11392061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of cyclic and continuous oral clodronate therapy on bone density and markers in osteopenic postmenopausal women.
    Tsai KS; Hsu SH; Yang RS; Cheng WC; Chieng PU
    Calcif Tissue Int; 1999 May; 64(5):384-8. PubMed ID: 10203414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
    Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
    J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial.
    McDonald CF; Zebaze RM; Seeman E
    Osteoporos Int; 2006 Oct; 17(10):1546-51. PubMed ID: 16832714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
    Monadi M; Javadian Y; Cheraghi M; Heidari B; Amiri M
    Osteoporos Int; 2015 Jul; 26(7):2013-8. PubMed ID: 25860975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P; Li F; Todd P; Webber D; Pack S; Moniz C
    Thorax; 1998 May; 53(5):351-6. PubMed ID: 9708225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate.
    Herrala J; Puolijoki H; Impivaara O; Liippo K; Tala E; Nieminen MM
    Bone; 1994; 15(6):621-3. PubMed ID: 7873290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroid use and bone-mineral density in patients with asthma.
    Wong CA; Walsh LJ; Smith CJ; Wisniewski AF; Lewis SA; Hubbard R; Cawte S; Green DJ; Pringle M; Tattersfield AE
    Lancet; 2000 Apr; 355(9213):1399-403. PubMed ID: 10791523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer.
    Powles TJ; McCloskey E; Paterson AH; Ashley S; Tidy VA; Nevantaus A; Rosenqvist K; Kanis J
    J Natl Cancer Inst; 1998 May; 90(9):704-8. PubMed ID: 9586668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.